FDA
-
-
-
-
-
-
-
TYRA appoints Bhavesh Ashar as COO and Heather Faulds as CRO
-
-
-
-
-
-
-
Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights
-
-
-
-
-
-
-
Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
-
-
-
-
-
-
-
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
-
-
-
-
-
-
-
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
-
-
-
-
-
-
-
Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia
-
-
-
-
-
-
-
Tyra Biosciences Announces Planned Chief Financial Officer Transition
-
328,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

